Coral Biotechnology, Inc is a biotechnology company founded in 2016 that offers contract research services for molecular analysis. The company specializes in clinical trials and biomarker investigations, recruiting laboratory studies for gene expression analysis, genomics, and epigenetics within the fields of Biotechnology and Industrial.
As of now, there is no public information available about the last investment received by Coral Biotechnology, Inc or the associated investors involved.
Overall, Coral Biotechnology, Inc is positioned in a niche segment of the biotechnology industry, offering services that cater to the growing demand for molecular analysis in clinical trials and laboratory studies. Its innovative approach and focus on molecular research make it an interesting prospect for potential investors looking to tap into the evolving biotechnology landscape.
